| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |